The trademark UNIPHARMA N-MMUNE was filed by Unipharma, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on March 9, 2020, and received one opposition filed on June 8, 2020 by Unipharma on Likelihood of confusion. the opponent was represented by MERK-ECHT B.V. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 8, 2020
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).